BG106524A - Piperidine quinolyl propyl derivatives and their use as antibacterial means - Google Patents

Piperidine quinolyl propyl derivatives and their use as antibacterial means

Info

Publication number
BG106524A
BG106524A BG106524A BG10652402A BG106524A BG 106524 A BG106524 A BG 106524A BG 106524 A BG106524 A BG 106524A BG 10652402 A BG10652402 A BG 10652402A BG 106524 A BG106524 A BG 106524A
Authority
BG
Bulgaria
Prior art keywords
piperidine
quinolyl propyl
antibacterial means
propyl derivatives
hydrogen
Prior art date
Application number
BG106524A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jean-Luc Malleron
Michel Tabart
Jean-Christophe Carry
Michel Evers
Ahmad Youssef El
Serge Mignani
Fabrice Viviani
Michel Cheve
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG106524A publication Critical patent/BG106524A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG106524A 1999-09-17 2002-03-15 Piperidine quinolyl propyl derivatives and their use as antibacterial means BG106524A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (fr) 1999-09-17 1999-09-17 Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2000/002541 WO2001025227A2 (fr) 1999-09-17 2000-09-14 Derives de la quinolyl propyl piperidine et leur utilisation en tant que antibacteriens

Publications (1)

Publication Number Publication Date
BG106524A true BG106524A (en) 2003-01-31

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106524A BG106524A (en) 1999-09-17 2002-03-15 Piperidine quinolyl propyl derivatives and their use as antibacterial means

Country Status (30)

Country Link
EP (2) EP1218370B1 (pl)
JP (1) JP2004527448A (pl)
KR (1) KR20020038757A (pl)
CN (1) CN1374959A (pl)
AP (1) AP2002002459A0 (pl)
AT (1) ATE284399T1 (pl)
AU (1) AU7429500A (pl)
BG (1) BG106524A (pl)
BR (1) BR0014060A (pl)
CA (1) CA2383836A1 (pl)
CZ (1) CZ2002940A3 (pl)
DE (2) DE60034713T2 (pl)
DZ (1) DZ3195A1 (pl)
EA (1) EA005183B1 (pl)
EE (1) EE200200138A (pl)
FR (1) FR2798656B1 (pl)
GE (1) GEP20043223B (pl)
HR (1) HRP20020214A2 (pl)
HU (1) HUP0204283A3 (pl)
IL (1) IL148720A0 (pl)
MA (1) MA26820A1 (pl)
MX (1) MXPA02001979A (pl)
NO (1) NO20021253L (pl)
OA (1) OA12022A (pl)
PL (1) PL354809A1 (pl)
SK (1) SK3632002A3 (pl)
TN (1) TNSN00184A1 (pl)
WO (1) WO2001025227A2 (pl)
YU (1) YU19002A (pl)
ZA (1) ZA200202073B (pl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
NZ523749A (en) 2000-07-26 2005-03-24 Smithkline Beecham P Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
EP1551829B1 (de) * 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
ES2340484T3 (es) 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
ATE411312T1 (de) 2002-12-04 2008-10-15 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
EP1799674B1 (en) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. New piperidine antibiotics
DE602005021133D1 (de) * 2004-10-05 2010-06-17 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
JP2008528588A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1846416A4 (en) 2005-01-25 2009-07-01 Glaxo Group Ltd ANTIBACTERIAL AGENTS
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
CN101374831B (zh) 2006-01-26 2011-04-27 埃科特莱茵药品有限公司 四氢吡喃抗生素
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
AU2008249745B2 (en) * 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
US9663486B2 (en) * 2013-10-14 2017-05-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
CA2958800C (en) 2014-08-22 2020-10-27 Glaxosmithkline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
MX2021006804A (es) 2015-12-17 2023-01-13 Merck Patent Gmbh Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
EP4198031A1 (en) 2016-08-08 2023-06-21 Merck Patent GmbH Tlr7/8 antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
JP2002535323A (ja) * 1999-01-20 2002-10-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー プロテインキナーゼ阻害剤としてのピペリジニルキノリン

Also Published As

Publication number Publication date
PL354809A1 (pl) 2004-02-23
YU19002A (sh) 2005-06-10
ZA200202073B (en) 2003-08-27
MA26820A1 (fr) 2004-12-20
MXPA02001979A (es) 2002-08-20
EA005183B1 (ru) 2004-12-30
EP1218370B1 (fr) 2004-12-08
GEP20043223B (en) 2004-04-26
FR2798656B1 (fr) 2004-12-17
TNSN00184A1 (fr) 2005-11-10
EP1484328B1 (fr) 2007-05-02
CN1374959A (zh) 2002-10-16
WO2001025227A2 (fr) 2001-04-12
OA12022A (fr) 2006-04-19
BR0014060A (pt) 2002-05-21
SK3632002A3 (en) 2003-04-01
NO20021253D0 (no) 2002-03-13
EA200200374A1 (ru) 2002-10-31
ATE284399T1 (de) 2004-12-15
WO2001025227A3 (fr) 2001-11-22
FR2798656A1 (fr) 2001-03-23
NO20021253L (no) 2002-04-24
HUP0204283A3 (en) 2004-07-28
JP2004527448A (ja) 2004-09-09
DE60034713D1 (de) 2007-06-14
DE60016611D1 (de) 2005-01-13
IL148720A0 (en) 2002-09-12
CZ2002940A3 (cs) 2002-07-17
DZ3195A1 (fr) 2001-04-12
HRP20020214A2 (en) 2005-04-30
KR20020038757A (ko) 2002-05-23
EP1218370A2 (fr) 2002-07-03
EE200200138A (et) 2003-06-16
CA2383836A1 (fr) 2001-04-12
DE60016611T2 (de) 2005-12-22
AU7429500A (en) 2001-05-10
EP1484328A1 (fr) 2004-12-08
AP2002002459A0 (en) 2002-06-30
HUP0204283A2 (hu) 2003-04-28
DE60034713T2 (de) 2008-01-17

Similar Documents

Publication Publication Date Title
WO2001025227A3 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant que antibacteriens
AU674477B2 (en) Heterocyclic-cyclic amine derivatives
AU2002216214A1 (en) Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
BG103947A (en) Derivatives of 9-oxymerythromycin
GB9917408D0 (en) Compounds
AU4925199A (en) Quinolin-2-one derivatives useful as anticancer agents
MY137156A (en) Dual nk1/nk3 derivatives
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
CA2292359A1 (en) Novel azalides and methods of making same
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
NO20015172L (no) 1-metyl-erytromycin-derivater
CA2146763A1 (en) Quinolone and acridinone derivatives for the treatment of urinary incontinence
PL358666A1 (pl) Pochodne karbaminianu 2-hydroksymutyliny do stosowania przeciwbakteryjnego
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
CA2406685A1 (en) Oxadiazole derivatives having anticancer effects
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
BG105004A (en) Carbapenem derivatives, utilization thereof and intermediate compounds of the same
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
IL114968A0 (en) 1,4-dihydropyridine compounds
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
EP1121932A4 (en) MEDICINE FOR EYE DISEASES
YU46302A (sh) Supstituisani piroli
CA2374902A1 (en) Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation